Clinical Trial

Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)

Study acronym: LEAD-AP
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-23.
Trial Details
NCT Number NCT06798961
Lead Sponsor United States Naval Medical Center, San Diego
Conditions Cardiac Death, Cardiac Death, Sudden, Wolf Parkinson White Syndrome
Enrollment 1,000 participants
Start Date 2024-11-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-14